JLC says that it has failed to acquire Binex due to opposition of its large shareholders, although both companies signed a take-over contract with Binex, a biopharmaceutical firm on January 12.
JLC is keen on Binex's management and shares instead of investment on research and development projects, said a senior official of Binex.
BINEX started its name of Soon Chun Dang but it was changed...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.